Found: 22
Select item for more details and to access through your institution.
Zanubrutinib more effective and better tolerated than ibrutinib for chronic lymphocytic leukemia and small lymphocytic lymphoma.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 10, p. 1466, doi. 10.1002/cncr.34811
- By:
- Publication type:
- Article
FDA grants accelerated approval of mosunetuzumab for relapsed, refractory follicular lymphoma.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 10, p. 1465, doi. 10.1002/cncr.34810
- By:
- Publication type:
- Article
First person profile: Otis W. Brawley, MD: Dr Brawley has spent years questioning the status quo of cancer screening assumptions, building a career on improving care for patients with cancer through more thorough applications of what data show on health disparities
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 10, p. 1464, doi. 10.1002/cncr.34809
- By:
- Publication type:
- Article
Reply to "Hepatocellular carcinoma in thalassemia and other hemoglobinopathies".
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 10, p. 1616, doi. 10.1002/cncr.34736
- By:
- Publication type:
- Article
Erratum to "Landscape of DNA damage response gene alterations in breast cancer: A comprehensive investigation".
- Published in:
- 2023
- Publication type:
- Correction Notice
Hepatocellular carcinoma in thalassemia and other hemoglobinopathies.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 10, p. 1614, doi. 10.1002/cncr.34735
- By:
- Publication type:
- Article
Top advances of the year: Neuro‐oncology.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 10, p. 1467, doi. 10.1002/cncr.34711
- By:
- Publication type:
- Article
Chemotherapy with the use of next‐generation tyrosine kinase inhibitors based on measurable residual disease has the potential to avoid hematopoietic stem cell transplantation in treatment for adults with Philadelphia chromosome–positive acute lymphoblastic leukemia
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 10, p. 1523, doi. 10.1002/cncr.34710
- By:
- Publication type:
- Article
A phase 1/2a safety, pharmacokinetics, and efficacy study of the novel nucleoside analog FF‐10502‐01 for the treatment of advanced solid tumors.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 10, p. 1537, doi. 10.1002/cncr.34709
- By:
- Publication type:
- Article
Is repeat sentinel lymph node biopsy possible for surgical axillary staging among patients with ipsilateral breast tumor recurrence?
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 10, p. 1492, doi. 10.1002/cncr.34708
- By:
- Publication type:
- Article
Applying a risk prediction model for bloodstream infection in a febrile, nonseverely neutropenic cohort of pediatric stem cell transplant patients.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 10, p. 1591, doi. 10.1002/cncr.34703
- By:
- Publication type:
- Article
Loss to follow‐up of minorities, adolescents, and young adults on clinical trials: A report from the Children's Oncology Group.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 10, p. 1547, doi. 10.1002/cncr.34701
- By:
- Publication type:
- Article
Vulnerable populations in childhood cancer research and clinical care.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 10, p. 1476, doi. 10.1002/cncr.34702
- By:
- Publication type:
- Article
Dietary supplement use among adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort Study.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 10, p. 1602, doi. 10.1002/cncr.34700
- By:
- Publication type:
- Article
Accelerometer‐measured physical activity and postmenopausal breast cancer incidence in the Women's Health Accelerometry Collaboration.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 10, p. 1579, doi. 10.1002/cncr.34699
- By:
- Publication type:
- Article
TET2 and LILRB1 mutations are frequent in Epstein–Barr virus‐positive diffuse large B‐cell lymphoma especially in elderly patients.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 10, p. 1502, doi. 10.1002/cncr.34698
- By:
- Publication type:
- Article
Safety, efficacy, and pharmacokinetics of SH‐1028 in EGFR T790M‐positive advanced non–small cell lung cancer patients: A dose‐escalation phase 1 study.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 10, p. 1513, doi. 10.1002/cncr.34697
- By:
- Publication type:
- Article
Understanding the role of access in Hispanic cancer screening disparities.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 10, p. 1569, doi. 10.1002/cncr.34696
- By:
- Publication type:
- Article
Malignancy in pregnancy: Multimodality imaging and treatment.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 10, p. 1479, doi. 10.1002/cncr.34688
- By:
- Publication type:
- Article
Association between major discrimination and deficit accumulation in African American cancer survivors: The Detroit Research on Cancer Survivors Study.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 10, p. 1557, doi. 10.1002/cncr.34673
- By:
- Publication type:
- Article
Care of the pregnant patient with cancer should include unfettered access to abortion.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 10, p. 1473, doi. 10.1002/cncr.34686
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 10, p. 1457, doi. 10.1002/cncr.33711
- Publication type:
- Article